A Study of NBL-012 in Healthy Chinese Subjects
NCT05259189
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
NBL-012 Injection
DRUG:
Placebo
Sponsor
NovaRock Biotherapeutics, Ltd